{"id":26406,"date":"2010-07-29T01:21:45","date_gmt":"2010-07-29T01:21:45","guid":{"rendered":"http:\/\/euvolution.com\/futurist-transhuman-news-blog\/sipuleucel-t-linked-to-prostate-cancer-survival-benefit-appears-to-prolong-modernmedicine\/"},"modified":"2010-07-29T01:21:45","modified_gmt":"2010-07-29T01:21:45","slug":"sipuleucel-t-linked-to-prostate-cancer-survival-benefit-appears-to-prolong-modernmedicine","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medical-school\/sipuleucel-t-linked-to-prostate-cancer-survival-benefit-appears-to-prolong-modernmedicine.php","title":{"rendered":"Sipuleucel-T Linked to Prostate Cancer Survival Benefit Appears to prolong … – ModernMedicine"},"content":{"rendered":"
\"\"
Reuters<\/a><\/td>
\"\"<\/div>
Sipuleucel-T Linked to Prostate Cancer Survival Benefit Appears to prolong ...<\/b><\/b><\/a>
ModernMedicine<\/b>
Philip W. Kantoff, MD, of Harvard Medical School<\/b> in Boston, and colleagues analyzed data from 512 patients with metastatic castration-resistant prostate ...<\/b>
Dr. Otis Brawley: Study Sees Aggressive Treatment for Low-Risk Prostate Cancer<\/a>Vitals Spotlight
Profile: Most Low-Risk Prostate Cancer Patients Receive Aggressive Treatment<\/a>Newswise (press release)
Most Men With Low-Risk Prostate Cancer Too Often Get High-Risk Treatment<\/a>Medscape
MSN Health & Fitness<\/a> -WebMD<\/a> -Wall Street Journal (blog)<\/a>
all 140 news articles »<\/b><\/a><\/div><\/td><\/tr><\/table>","protected":false},"excerpt":{"rendered":"

ReutersSipuleucel-T Linked to Prostate Cancer Survival Benefit Appears to prolong ...ModernMedicinePhilip W. Kantoff, MD, of Harvard Medical School in Boston, and colleagues analyzed data from 512 patients with metastatic castration-resistant prostate ...Dr. Otis Brawley: Study Sees Aggressive Treatment for Low-Risk … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[36],"tags":[],"class_list":["post-26406","post","type-post","status-publish","format-standard","hentry","category-medical-school"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/26406"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=26406"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/26406\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=26406"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=26406"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=26406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}